| Literature DB >> 33720891 |
Emilia Schwertner1, Renata Zelic2, Juraj Secnik1, Björn Johansson3,4, Bengt Winblad3,5, Maria Eriksdotter1,3, Dorota Religa1,3.
Abstract
BACKGROUND: In Sweden, 2,296,000 firearms were legally owned by private persons in 2017 and there were 150,000 persons living with a dementia diagnosis. A proportion of these persons owning a firearm may pose safety concerns.Entities:
Keywords: Alzheimer’s disease; behavioral and psychological symptoms of dementia; dementia; firearm; frontotemporal; neuropsychiatric symptoms; risk assessment; vascular; violence
Year: 2021 PMID: 33720891 PMCID: PMC8203223 DOI: 10.3233/JAD-201365
Source DB: PubMed Journal: J Alzheimers Dis ISSN: 1387-2877 Impact factor: 4.472
Characteristics of patients with and without a firearm
| Firearm ownership status | ||||||
| No | Yes | Missing | ||||
| ( | ( | ( | ||||
| % | % | % | ||||
| Diagnosis | ||||||
| Alzheimer’s disease | 16,197 | 31.4 | 580 | 31.8 | 3,375 | 27.4 |
| Frontotemporal dementia | 795 | 1.5 | 54 | 3.0 | 138 | 1.1 |
| Lewy body dementia | 1,855 | 3.6 | 103 | 5.7 | 358 | 2.9 |
| Mixed dementia | 10,305 | 20.0 | 318 | 17.4 | 1,427 | 11.6 |
| Vascular dementia | 9,939 | 19.3 | 369 | 20.2 | 2,069 | 16.8 |
| Other | 1,181 | 2.3 | 37 | 2.0 | 475 | 3.8 |
| Unspecified | 11,289 | 21.9 | 362 | 19.9 | 4,491 | 36.4 |
| Age | ||||||
| < 74 | 9,889 | 19.2 | 505 | 27.8 | 2,254 | 18.3 |
| 74–78.9 | 10,098 | 19.6 | 466 | 25.6 | 2,438 | 19.8 |
| 79–84 | 12,950 | 25.2 | 479 | 26.3 | 3,137 | 25.5 |
| > 84 | 18,551 | 36.0 | 370 | 20.3 | 4,465 | 36.3 |
| Missing | 73 | - | 3 | - | 39 | - |
| Gender | ||||||
| Female | 31,628 | 61.3 | 176 | 9.7 | 6,985 | 56.6 |
| Male | 19,933 | 38.7 | 1,647 | 90.4 | 5,348 | 43.3 |
| Mini-Mental State Examination | ||||||
| Very severe (0–10) | 1,678 | 3.5 | 47 | 2.7 | 439 | 4.1 |
| Moderate severe (11–18) | 11,992 | 24.8 | 363 | 20.7 | 2,824 | 26.7 |
| Moderate (19–23) | 18,366 | 38.0 | 656 | 37.4 | 3,883 | 36.7 |
| Mild (24–30) | 16,239 | 33.6 | 689 | 39.3 | 3,446 | 32.5 |
| Missing | 3,286 | - | 68 | - | 1,741 | - |
| Living arrangements | ||||||
| Living alone | 23,962 | 46.7 | 1 280 | 70.5 | 5,567 | 47.1 |
| Living with another person | 21,924 | 42.7 | 464 | 25.6 | 4,524 | 38.3 |
| Nursing home | 5,439 | 10.6 | 72 | 4.0 | 1,723 | 14.6 |
| Missing | 236 | - | 7 | - | 519 | - |
| Diagnostic institution | ||||||
| Memory Clinic | 30,202 | 58.6 | 1 065 | 58.4 | 5,013 | 40.7 |
| Primary care | 21,359 | 41.4 | 758 | 41.6 | 7,320 | 59.4 |
| Daycare | ||||||
| No | 48,315 | 95.8 | 1 738 | 97.3 | 10,433 | 96.0 |
| Yes | 2,137 | 4.2 | 48 | 2.7 | 439 | 4.0 |
| Missing | 1,109 | - | 37 | - | 1,461 | - |
| Homecare | ||||||
| No | 33,844 | 66.6 | 1 473 | 82.2 | 7,680 | 69.5 |
| Yes | 16,942 | 33.4 | 318 | 17.8 | 3,369 | 30.5 |
| Missing | 775 | - | 32 | - | 1,284 | - |
| N-Methyl-D-aspartate receptor antagonists | ||||||
| No | 44,539 | 88.7 | 1 595 | 89.3 | 10,055 | 92.2 |
| Yes | 5,673 | 11.3 | 192 | 10.7 | 854 | 7.8 |
| Missing | 1,349 | - | 36 | - | 1,424 | - |
| Acetylcholinesterase inhibitors | ||||||
| No | 28,786 | 56.9 | 941 | 52.3 | 6,372 | 57.3 |
| Yes | 21,777 | 43.1 | 860 | 47.8 | 4,756 | 42.7 |
| Missing | 998 | - | 22 | - | 1,205 | - |
| Vascular drugs | ||||||
| No | 15,382 | 30.7 | 505 | 28.3 | 3,639 | 33.2 |
| Yes | 34,766 | 69.3 | 1 277 | 71.7 | 7,340 | 66.9 |
| Missing | 1,413 | - | 41 | - | 1,354 | - |
| Antidepressants | ||||||
| No | 65,683 | 71.3 | 1 346 | 75.8 | 7,600 | 69.8 |
| Yes | 14,385 | 28.7 | 431 | 24.3 | 3,284 | 30.2 |
| Missing | 1,493 | - | 46 | - | 1,449 | - |
| Antipsychotics | ||||||
| No | 46,989 | 94.0 | 1,704 | 96.0 | 9,812 | 91.2 |
| Yes | 2,986 | 5.0 | 72 | 4.1 | 949 | 8.8 |
| Missing | 1,586 | - | 47 | - | 1,572 | - |
| Hypnotics | ||||||
| No | 41,388 | 82.9 | 1,587 | 89.6 | 8,632 | 80.1 |
| Yes | 8,530 | 17.1 | 184 | 10.4 | 2,144 | 19.9 |
| Missing | 1,643 | - | 52 | - | 1,557 | - |
| Anxiety suppressors | ||||||
| No | 44,564 | 89.2 | 1,655 | 93.3 | 9,182 | 85.1 |
| Yes | 5,407 | 10.8 | 119 | 6.7 | 1,612 | 14.9 |
| Missing | 1,590 | - | 49 | - | 1,539 | - |
| Reported | ||||||
| Yes | - | - | 346 | 22.2 | 73 | 1.9 |
| No | 51,561 | 100.0 | 1,212 | 77.8 | 3,876 | 98.2 |
| Missing | - | - | 265 | - | 8,384 | - |
Odds ratios (OR) and 95% confidence intervals (CI) and the relative importance indicators (standardized coefficients (SC) and dominance rank (DR) based on the standardized general dominance statistic (SGDS)) of the association between predictors and being reported to the police as unsuitable to own a firearm
| OR (95% CI) | SC | SGDS | DR | |
| Diagnosis | ||||
| Alzheimer’s disease | Ref | Ref | 0.011 | 2 |
| Frontotemporal dementia | 3.1 (1.56–6.18) | 0.180 | ||
| Lewy body dementia | 0.89 (0.53–1.5) | –0.030 | ||
| Mixed dementia | 1.45 (1.06–2.16) | 0.149 | ||
| Vascular dementia | 1.38 (0.88–2.16) | 0.131 | ||
| Other | 1.59 (0.75–3.36) | 0.075 | ||
| Unspecified | 1.21 (0.83–1.78) | 0.080 | ||
| Age | ||||
| < 74 | Ref | Ref | 0.0026 | 9 |
| 74–78 | 1.22 (0.74–2) | 0.053 | ||
| 79–84 | 1.22 (0.75–2) | 0.051 | ||
| > 84 | 0.89 (0.51–1.55) | –0.074 | ||
| Gender | ||||
| Female versus Male | 1.79 (1.2–2.67) | 0.177 | 0.0084 | 5 |
| Mini-Mental State Examination | ||||
| Very severe (0–10) | Ref | Ref | 0.0072 | 6 |
| Moderate severe (11–18) | 0.97 (0.5–1.9) | –0.012 | ||
| Moderate (19–23) | 0.65 (0.35–1.22) | –0.209 | ||
| Mild (24–30) | 0.6 (0.32–1.13) | –0.245 | ||
| Living arrangements | ||||
| Living alone | Ref | Ref | 0.0166 | 1 |
| Nursing Home | 2.14 (1.25–3.64) | 0.152 | ||
| Living with another person | 1.67 (1.17–2.38) | 0.232 | ||
| Diagnosing unit | ||||
| Primary care versus Memory Clinic | 0.59 (0.44–0.78) | –0.266 | 0.0094 | 4 |
| Daycare | ||||
| Yes versus no | 0.87 (0.4–1.89) | –0.030 | 0 | 14 |
| Homecare | ||||
| Yes versus no | 1.18 (0.86–1.63) | 0.063 | 0.0028 | 8 |
| N-Methyl-D-aspartate receptor antagonists | ||||
| Yes versus no | 0.94 (0.59–1.5) | –0.009 | 0 | 14 |
| Acetylcholinesterase inhibitors | ||||
| Yes versus no | 0.91 (0.66–1.27) | –0.050 | 0.002 | 10 |
| Vascular drugs | ||||
| Yes versus no | 0.84 (0.65–1.08) | –0.084 | 0.0014 | 12 |
| Antidepressants | ||||
| Yes versus no | 0.74 (0.52–1.06) | –0.135 | 0.0018 | 11 |
| Antipsychotics | ||||
| Yes versus no | 2.42 (1.35–4.35) | 0.184 | 0.0098 | 3 |
| Hypnotics | ||||
| Yes versus no | 1.77 (1.21–2.59) | 0.171 | 0.0072 | 7 |
| Anxiety suppressors | ||||
| Yes versus no | 0.88 (0.56–1.37) | –0.033 | 0 | 14 |